A.I.R-e

  • DATABASE (2662)

  • ARTICLES (286)

    • DATABASE (2662)
    • ARTICLES (286)
  • Sort by
    • Relevance
    • Date

Established in 1958, VERSO Capital is a boutique merchant banking and financial services firm based in Luxembourg. It also has offices in Geneva, Fribourg, Vaduz, Dubai, Singapore and BVI. VERSO specializes in sectors like education, food and renewables. Since 2011, the firm has invested over $700bn in venture capital in the global startup ecosystem. Funds worth over $245m were pumped into climatech, foodtech and biotech sectors since 2017. In February 2021, it merged with Swiss alternative asset manager ALDINI Capital that was also founded in 1958 and based in Switzerland and Liechtenstein. VERSO will leverage the expertise of ALDINI in hedge funds, private equity and real estate.

Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.

Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them.  Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber.  Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.

Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals.  Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech. 

DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.

Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.

New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio.  Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech. 

Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise).  He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.

Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.

BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms. 

Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups.  It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020. 

Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies.  His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.

FBG Invest is an industry network of investors based in Falkenberg, south Sweden. The network focuses on VC investments in local enterprises. Besides Mycorena in Gothenburg, FBG’s other investment is Consumiq that runs a Swedish grocery shopping app matlistan.

Falkenbergs Sparbanks Foundation is part of the Swedish savings bank in the municpality of Falkenberg. Falkenbergs Sparbank is the 37th largest bank in Sweden in terms of total assets.

Based in the municipality of Falkenburg, the Bertebos Foundation was founded in 1994 by Olof and Brita Stenström to promote education and scientific research in the food industry. The family-run foundation holds 30% shares in the family business Bertegruppen AB. The group’s food brand portfolio includes producer of ice-cream and sorbets SIA Glass and Berte Qvarn that runs a dairy farm, flour mill and bakery. 

Sorry, we couldn’t find any matches for “A.I.R-e”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.